PFG Private Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-100
Closed -$6.1K 79
2025
Q1
$6.1K Hold
100
﹤0.01% 169
2024
Q4
$5.66K Hold
100
﹤0.01% 148
2024
Q3
$5.17K Hold
100
﹤0.01% 161
2024
Q2
$4.15K Hold
100
﹤0.01% 164
2024
Q1
$5.42K Hold
100
﹤0.01% 150
2023
Q4
$5.13K Hold
100
﹤0.01% 158
2023
Q3
$5.8K Sell
100
-303
-75% -$18.6K ﹤0.01% 212
2023
Q2
$25.8K Hold
403
0.02% 169
2023
Q1
$27.9K Sell
403
-12
-3% -$846 0.02% 165
2022
Q4
$30K Sell
415
-39
-9% -$2.94K 0.02% 158
2022
Q3
$32K Buy
454
+51
+13% +$3.7K 0.02% 150
2022
Q2
$31K Hold
403
0.02% 168
2022
Q1
$29K Hold
403
0.01% 166
2021
Q4
$25K Sell
403
-50
-11% -$2.93K 0.01% 173
2021
Q3
$27K Buy
+453
New +$29.8K 0.02% 164

Other funds holding BMY

PFG Private Wealth Management's BMY Position: Q2 2025 in Review

PFG Private Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 100 shares — an estimated $6.1K sold.

PFG Private Wealth Management first reported a position in BMY in Q3 2021 and held it in 15 quarters. The position peaked at $32K in Q3 2022. 2,297 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • PFG Private Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • PFG Private Wealth Management sold 100 Bristol-Myers Squibb shares in Q2 2025, an estimated $6.1K.
  • PFG Private Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2021 and held it in 15 quarters.
  • PFG Private Wealth Management's Bristol-Myers Squibb position peaked at $32K in Q3 2022.
  • 2,297 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on PFG Private Wealth Management's 13F filing for Q2 2025, filed 11 Aug 2025.